In July 2016, the Colombian government enacted Law 1787, which regulates the use of medicinal cannabis and its trade in the country. With this decision and a series of subsequent resolutions, Colombia joined the more than a dozen countries that have put into practice different types of regulation to explore the advantages of this plant as an alternative pharmaceutical.
The Caribbean trade bloc Caricom has created a commission to study whether the region's roughly 15 million people should be allowed to use medical marijuana and how courts should handle possession of small amounts of the drug. Leaders said that the commission is expected to submit reports by Caricom's next summit, scheduled for February 2016. A recent preliminary report from Caricom found that decriminalizing medical marijuana could help boost the region's economy. (See also: Opposition says Jamaica does not need Caricom ganja comm)
La légalisation du cannabis en Maroc à des fins thérapeutiques et industrielles permettra les familles de vivre dignement. Après le Parti de l’Istiqlal, le PAM s’apprête à déposer lui aussi une proposition de loi en ce mois de février après avoir terminé ses consultations avec les agriculteurs. Le sujet en tout cas n’est plus tabou, et les parlementaires eux-mêmes, au-delà des calculs électoralistes et politiques que peut revêtir leur initiative, demandent à juste titre un cadre législatif pour son exploitation à des fins médicales et industrielles.
In a decision that could have immediate fallout for medical marijuana dispensaries, a state appeals court has ruled that California law allows cities and counties to ban the stores. The contentious issue has bounced through the state courts for years, but the opinion issued Wednesday is the first published one that directly tackles it and does so in unambiguous language. The decision could embolden more cities and counties to enact their own. It also could spur those that have bans to be more aggressive about seeking court orders to close defiant dispensaries.
A UCSF study suggests patients with chronic pain may experience greater relief if their doctors add cannabinoids - the main ingredient in cannabis or medical marijuana - to an opiates-only treatment. The findings, from a small-scale study, also suggest that a combined therapy could result in reduced opiate dosages. Cannabidiol, or CBD, appears to be very effective against pain and inflammation without creating the "high" created by THC.
Voters narrowly approved a ballot initiative last November allowing medical marijuana in the state, but the result has been just the opposite of an orderly system of dispensing cannabis to the truly sick. Rather, police raids, surreptitious money transfers and unofficial pot clubs have followed passage of the new law, creating a chaotic situation not far removed from the black-market system that has always existed.
For the past three decades, Uncle Sam has been providing patients with some of the highest grade marijuana around as part of a little-known program that grew out of a 1976 court settlement and created the country's first legal pot smoker. The program once provided 14 people government pot. Now, there are four left.
Health Canada began two days of closed-door talks Wednesday about changes to the controversial medical marijuana law that has faced legal challenges and criticism for being ineffective. But even as meetings get underway in Ottawa, there are concerns Health Canada is on the wrong track with a law that asks doctors to ignore a sworn obligation to protect patients’ health, while forcing patients to go to great lengths to obtain a drug that many say eases their pain.
The California Medical Association, representing more than 35,000 physicians statewide, questions the medical value of pot and acknowledges some health risk from its use but urges it be regulated like alcohol. It is the first major medical association in the nation to urge legalization of the drug. Dr. Donald Lyman, who wrote the group's new policy, attributed the shift to growing frustration over California's medical marijuana law, which permits cannabis use with a doctor's recommendation. That has created an untenable situation for physicians: deciding whether to give patients a substance that is illegal under federal law.
The uncertainty comes after lawmakers worked for months on a plan that would help clear up the state's medical marijuana laws. The Legislature approved a plan that would have created a system to regulate medical marijuana dispensaries. But Gregoire, citing fears that state workers could face federal prosecution for participating in the licensing scheme, vetoed much of it. The remaining parts of the law allow collective marijuana grows with up to 45 plants, serving up to 10 patients.
Pien Metaal, who follows Latin American drug law reform ... told The Tico Times ... that legalizing medical marijuana in Costa Rica “would clearly send a message that can spark a debate in the region... Of course, the debate should not just be about medicinal use,” Metaal wrote, “since in fact recreational use is the largest actually existing phenomena, [for] which simple possession and use are being criminalized and prosecuted.”
Eliseu Labigalini Jr, Lucio Ribeiro Rodrigues, Dartiu Xavier Da Silveira
01 October 1999
This study ensued from clinical observations based on spontaneous accounts by crack abusers undergoing their first psychiatric assessment, where they reported using cannabis in an attempt to ease their own withdrawal symptoms.
Last week's request by Govs. Chris Gregoire and Rhode Island's Lincoln Chafee to have the federal government reclassify marijuana as medicine--which at first glance looked like unalloyed good news for those who support safe access for patients--is actually a double-edged sword.
A high-ranking U.S. Justice Department official who wrote a memo saying state medical marijuana laws do not provide immunity from federal prosecution refused to say whether a recent crackdown in California signals a shift in federal policy that may result in a crackdown in other states. Deputy Attorney General James Cole said the memo sent to U.S. attorneys in June speaks for itself, and he said U.S. attorneys have discretion in how federal law is enforced in their districts.
The organisers of a Czech petition for the legalisation of cannabis in medical treatment have asked Prime Minister Petr Necas to support the relevant changes in legislation. The petition committee, including doctors, patients and scientists, recalls that it does not seek the legalisation of marijuana for recreational use. Since its launch on August 16, the petition has been signed by almost 5,000 people.
Recently, the California Medical Association, representing more than 35,000 physicians, the largest statewide physician organization in America, boldly decided to adopt a different, more pragmatic approach to the polarizing issue of marijuana decriminalization. The decision – the result of a carefully considered process, painstakingly researched and debated for more than one year – is centered on one concern above all others: patient safety.
Like every section that's left of the mostly vetoed medical-marijuana-reform law that passed in April, section 403 is vague, confusing, and inadequate to the task of regulating cannabis. Section 403, however, might be the single most important scrap of law to survive Gov. Chris Gregoire's veto pen. It's from this section, after all, that the City of Seattle, just three days ago, effectively legalized medical-marijuana gardens and dispensaries (city officials prefer the term "access points").
In October 2009, medical marijuana advocates celebrated a U.S. Department of Justice memo declaring that federal authorities wouldn't target the legal use of medicinal pot in states where it is permitted. The memo from Deputy U.S. Attorney General David Ogden was credited with accelerating a California medical marijuana boom, including a proliferation of dispensaries that now handle more than $1 billion in pot transactions. But last month brought a new memo from another deputy attorney general, James Cole. And this time, it is stirring industry fears of federal raids on pot dispensaries and sweeping crackdowns on large-scale medical pot cultivation.